Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Neoplasms 1Metabolic Diseases 1Anemia, Aplastic 1

Interventions

Dalteparin 10apixaban 5Tinzaparin 4Enoxaparin 4Heparin, Low-Molecular-Weight 3edoxaban 2bemiparin 2abelacimab 2Warfarin 2MAA868 2Fondaparinux 2Dabigatran 2reviparin 1isoquercitrin 1certoparin 1calcium heparin 1acarboxyprothrombin 1Rosuvastatin Calcium 1Rivaroxaban 1Phenprocoumon 1Nadroparin 1Heparin 1Educational Status 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venous Thrombosis × Heparin × Classical hematology × Clear all
NCT01444612 2017-05-16

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

GlaxoSmithKline

Completed
4,068 enrolled
Classical hematology

Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡